Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of TBR-760 in adults with residual non-functioning pituitary adenoma after transsphenoidal surgery
MOH_2020-06-01_008996Phase 3Completed
- Sponsor
- Tiburio Therapeutics
- Start
- Mar 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chromophobe adenoma comparing TBR-760 with Placebo (2 arms). Started Mar 2020; status: completed.
02
Drugs
onzigolide
03
Conditions
chromophobe adenoma
Beyond the preview
Go deeper on MOH_2020-06-01_008996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-06-01_008996.